查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2033133

糖尿病護理設備市場規模、佔有率、趨勢和預測：按類型、分銷管道、最終用戶和地區分類，2026-2034 年

Diabetes Care Devices Market Size, Share, Trends and Forecast by Type, Distribution Channel, End User, and Region, 2026-2034
出版日期: | 出版商: IMARC | 英文 137 Pages | 商品交期: 2-3個工作天內

價格

2025年全球糖尿病護理設備市場規模為365億美元。展望未來，IMARC Group預測，該市場將在2026年至2034年間以6.35%的複合年成長率成長，到2034年達到645億美元。目前，北美市場佔據主導地位，預計2025年市佔率將超過38.6%。糖尿病發病率上升、技術快速發展、政府支持措施、可支配收入增加、巨量資料和分析技術的應用以及老年人口的成長是推動市場發展的主要因素。

由於人口老化、久坐生活方式的增加以及不良飲食習慣導致糖尿病患者數量上升等因素，全球糖尿病護理設備市場正在不斷擴大。都市化進程持續加速，與肥胖率上升密切相關。持續血糖監測（CGM）系統、智慧胰島素筆和封閉回路型胰島素輸注等先進技術有助於提高患者遵從性和治療效果。各國政府為意識提升和促進早期診斷而採取的措施也推動了市場發展，尤其是在醫療基礎設施尚在發展的新興國家。

例如，2024年8月，Medtronic的一次性一體化設備Simplera™ CGM獲得FDA核准，並宣布與雅培公司建立全球夥伴關係關係，以拓展其持續血糖監測（CGM）解決方案。此外，糖尿病管理解決方案正隨著人工智慧（AI）和基於雲端的數據分析技術的快速發展而迅速進步，從而實現更強大的遠端監測功能。

開發中國家可支配收入和醫療保健支出的成長正在推動先進糖尿病護理設備的普及。報銷政策和監管核准也在加速創新和商業化進程。遠端醫療和數位化糖尿病管理平台的進步正在創造新的成長機遇，尤其是在遠端患者監護對慢性病管理日益重要的情況下。

美國糖尿病護理設備市佔率高達89.5%，這主要得益於患者對居家糖尿病管理解決方案的需求不斷成長，他們希望減少就醫次數。例如，2024年8月，德康醫療（Dexcom）推出了Stelo，這是美國首款商用血糖生物感測器。本產品無需處方箋或指尖採血，即可為第二型糖尿病和糖尿病前期患者提供全天候血糖值資訊。此外，完善的醫療保健基礎設施、研究設施和成熟的醫療保險報銷政策也為新型糖尿病管理設備和解決方案的推廣應用提供了支援。

在美國，隨著聯邦醫療保險和私人保險的覆蓋，持續血糖監測（CGM）設備的需求正在成長，尤其是在胰島素依賴型患者群體中。主要產業參與者的存在，以及美國食品藥物管理局（FDA）定期產品核可，正在推動技術的快速發展。消費者意識的提高以及對侵入性更小、更易於使用且具有治療益處的設備的需求，正在推動市場成長。

數位健康解決方案（例如行動應用程式和人工智慧驅動的糖尿病管理工具）的日益普及，正在提升患者的參與度。妊娠糖尿病和糖尿病前期盛行率的上升，進一步擴大了市場需求。官民合作關係和研究津貼正在促進持續創新，並加劇市場競爭。

糖尿病護理設備市場的發展趨勢：

糖尿病發生率上升

糖尿病盛行率的不斷上升是推動糖尿病護理設備市場成長的主要因素。這一成長主要源於各種生活方式的改變，例如久坐不動的生活方式以及高糖高脂食物攝取量的增加。此外，隨著糖尿病患者人數的增加，對高效管理和監測工具的需求也變得比以往任何時候都更加重要。截至2021年，全球約有5.37億成年人患有糖尿病，根據國際糖尿病聯盟（IDF）的估計，這一數字預計將持續成長，到2045年將達到7.83億。

因此，糖尿病照護設備正被廣泛用於改善血糖控制、降低併發症風險、減少急診就診次數、改善患者預後，並提供即時數據以支援快速決策。此外，高盛行率提高了人們的認知和緊迫感，推動了研發和創新方面的投資，從而加快了技術進步的步伐，使市場對潛在買家更具吸引力。

科技的快速發展

糖尿病護理設備市場正受到快速技術進步的影響，這些進步顯著提升了設備的準確性、易用性和便利性。持續血糖監測（CGM）系統的推出，能夠持續監測患者的血糖值，並提供即時血糖監測，有助於制定個人化治療方案和調整生活方式，並積極推動該市場的成長。根據產業報告預測，到2028年，CGM市場規模預計將達到200億美元。

此外，具備劑量計算功能的智慧胰島素筆代表了先進技術的巔峰之作，它徹底消除了胰島素實際注射過程中的猜測成分，也推動了該市場的成長。同時，具有連接功能的創新設備的開發，實現了醫護人員和患者之間無縫的數據共用，也促進了市場成長。

政府推出的利多政策

公共衛生政策和政府措施在糖尿病護理設備市場的成長中發揮重要作用。許多政府意識到糖尿病對醫療保健系統造成的沉重負擔，並採取積極措施應對。根據世界衛生組織統計，2021年，「全球有超過4.22億人患有糖尿病，估計全球整體經濟負擔約1.3兆美元」。在這方面，進行宣傳宣傳活動、教育大眾了解糖尿病風險和各種疾病管理方法的組織也為市場成長做出了貢獻。

此外，政府加大對糖尿病護理設備成本的補貼力度，使更多人能夠負擔得起這些設備，也促進了市場成長。同時，政府推出的各項報銷計劃，涵蓋了諸如持續血糖監測（CGM）等先進設備的費用，也推動了市場成長。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球糖尿病護理設備市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依類型

  • 血糖值監測（BGM）設備
    • 主要部分
      • 自測量設備
      • 連續血糖監測設備
  • 胰島素輸注裝置
    • 主要部分
      • 泵浦
      • 筆式胰島素注射器
      • 注射器
      • 噴射注射器

第7章 市場區隔：依分銷通路分類

  • 醫院藥房
  • 零售藥房
  • 糖尿病診所/中心
  • 網路藥房
  • 其他

第8章 市場區隔：依最終用戶分類

  • 醫院
  • 居家照護
  • 診斷中心
  • 門診手術中心

第9章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第10章 SWOT 分析

第11章：價值鏈分析

第12章：波特五力分析

第13章：價格分析

第14章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • Abbott Laboratories
    • ACON Laboratories Inc.
    • Ascensia Diabetes Care Holdings AG（PHC Holdings Corporation）
    • Becton Dickinson and Company
    • Bionime Corporation
    • Dexcom Inc.
    • F. Hoffmann-La Roche AG
    • Johnson & Johnson
    • Medtronic plc
    • Novo Nordisk A/S
    • Sinocare Inc.
    • Terumo Corporation
Product Code: SR112026A5746

The global diabetes care devices market size was valued at USD 36.5 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 64.5 Billion by 2034, exhibiting a CAGR of 6.35% from 2026-2034. North America currently dominates the market, holding a market share of over 38.6% in 2025. The rising incidences of diabetes, rapid technological advancements, imposition of favorable government initiatives, increasing disposable incomes, integration of big data and analytics, and escalating geriatric population are some of the major factors propelling the market.

The growing global market for diabetes care devices is triggered by a geriatric population, increasingly sedentary lifestyle, and poor diets leading to higher levels of diabetes cases. The urbanization pace continues to rise in conjunction with higher rates of obesity. Advanced technology in continuous glucose monitoring (CGM) systems, smart insulin pens, and closed-loop insulin delivery contributes to greater compliance and outcomes from the patients' end. Government efforts toward escalating diabetes awareness and early diagnosis also spur the market, especially in emerging economies with an improving healthcare infrastructure.

For instance, in August 2024, Medtronic received FDA approval for its Simplera(TM) CGM, a disposable, all-in-one device, and announced a global partnership with Abbott to expand continuous glucose monitoring (CGM) solutions. Moreover, diabetes management solutions are surged by artificial intelligence (AI) and cloud-based data analytics for better remote monitoring capabilities.

Rising disposable income and health care spending in developing economies enhance the adoption of advanced diabetes care devices. Reimbursement policies and regulatory approvals also speed up innovation and commercialization. The advancements in telehealth and in digital diabetes management platforms hold new growth opportunities, especially with remote patient monitoring becoming more critical in the management of chronic diseases.

The U.S. diabetes care devices market share is 89.5% owing to the accelerating demand from patients preferring home-based diabetes management solutions which will reduce their hospital visits. For example, in August 2024, Dexcom launched Stelo, the first over-the-counter glucose biosensor in the U.S., providing 24/7 glucose insights without prescriptions or fingersticks for individuals with Type 2 diabetes and prediabetes. Furthermore, well-developed healthcare infrastructure, research facilities, and established reimbursement policies support the use of novel diabetes management devices and solutions.

The demand for CGM devices is high in the country, especially in the case of insulin-dependent patients, since Medicare as well as private insurances cover such devices. The presence of key industry players, combined with regular product approvals by the U.S. FDA, favors fast-paced technological development. Heightened consumer awareness and preference for devices that are minimally invasive, user-friendly, and support therapeutic benefits drive market growth.

Greater adoption of digital health solution-based solutions, such as mobile apps and AI-based diabetes management tools, enhance patient engagement. The rising prevalence of gestational diabetes and prediabetes further amplifies the volume of demand. Public-private partnerships and research grants fuel continuous innovation, strengthening the market's competitive landscape.

Diabetes Care Devices Market Trends:

The Rising Incidence of Diabetes

The increasing prevalence of diabetes is a dominant factor fueling the diabetes care devices market growth. This escalation is primarily caused by various lifestyle changes, including sedentary habits and increasing consumption of high-sugar and high-fat diets. Furthermore, as the number of diabetes cases multiplies, the need for efficient management and monitoring tools becomes more critical than ever. In 2021, around 537 million adults worldwide have diabetes, a number that the International Diabetes Federation estimates will continue to rise and reach 783 million by 2045.

In line with this, diabetes care devices are widely used to improve glucose management, minimize the risks of complications, reduce emergency healthcare visits, increase patient outcomes, and provide real-time data for quick decision-making. Moreover, the high incidence rates lead to greater awareness and urgency, thereby encouraging more investments in research and innovation efforts to accelerate the pace of technological advancements, making the market even more attractive to potential buyers.

The Rapid Technological Advancements

The diabetes care devices market is being shaped by rapid technological advancements that offer improved precision, ease of use, and convenience. Continuous glucose monitoring systems are introducing CGMs, which observe the continuous glucose profile of a patient and provide real-time glucose monitoring, enhancing treatment customization and lifestyle adjustments that are positively influencing the growth in this market. According to an industry report, the CGM market is expected to capture sales of USD 20 Billion by 2028.

Additionally, in smart insulin pens having dose calculators, which are nothing but the incorporation of high sophistication by eliminating all the guesswork in the actual dosing of insulin, is contributing toward this market growth as well. Additionally, the development of innovative devices that are equipped with connectivity features, enabling seamless data sharing between healthcare professionals and patients, is favoring the market growth.

The Imposition of Favorable Government Initiatives

Public health policies and government initiatives play a significant role in the growth of the diabetes care devices market. Several governments are recognizing the burden that diabetes imposes on healthcare systems and are taking proactive measures to address it. According to WHO, in 2021, "over 422 million people across the world were suffering from this disease, which is estimated at around USD 1.3 trillion in its economic burden throughout the world globally." In continuation of this point, the marketing growth is contributed by organizations that organize information campaigns to advise the public in relation to a risk of encountering diabetes and various ways of disease management.

Moreover, the increasing allocation of funds by several governments to subsidize the cost of diabetes care devices, making them more accessible to a broader population, is contributing to the market growth. Besides this, the introduction of various reimbursement schemes to cover the cost of advanced devices, such as continuous glucose monitoring (CGMs) is contributing to the market growth.

Diabetes Care Devices Industry Segmentation:

The research provides an analysis of the key trends in each segment of the global diabetes care devices market report, along with forecasts at the global, regional and country levels from 2026-2034. Our report has categorized the market based on type, distribution channel, and end user.

Analysis by Type:

  • Blood Glucose Monitoring (BGM) Devices
  • Self-Monitoring Devices
  • Continuous Glucose Monitoring Devices
  • Insulin Delivery Devices
  • Pumps
  • Pens
  • Syringes
  • Jet Injectors

Blood Glucose Monitoring (BGM) leads the market with around 65.8% of market share in 2025. These devices are dominating the market as they are highly affordable, making them accessible to a broader range of consumers. Furthermore, they are designed for user-friendliness, often requiring just a small drop of blood for accurate glucose readings. Additionally, BGM devices offer near-instantaneous results, enabling immediate action if needed, such as adjusting insulin dosage or food intake.

Besides this, they are compact and easy to carry, making them convenient for people who are always on the go. This portability ensures that monitoring can happen anytime, anywhere. Moreover, BGM devices are being used for a longer period and enjoy broad acceptance among healthcare providers. In addition, they require minimal upkeep, usually replacement of test strips and occasional calibration, which makes them convenient for long-term use.

Analysis by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Diabetes Clinics/Centers
  • Online Pharmacies
  • Others

Hospital pharmacies lead the market with around 54.7% of market share in 2025. These are dominating the market as they are considered reliable and trustworthy sources for medical devices, including those for diabetes care. Furthermore, patients admitted for diabetes complications or those visiting for a routine check-up can quickly and conveniently purchase the required devices and supplies from the hospital pharmacy. In addition, they employ well-trained pharmacists who can provide expert advice on device usage, thereby adding an extra layer of reassurance for patients.

Besides this, products sold in hospital pharmacies are generally subject to rigorous quality checks, ensuring that patients receive authentic and effective devices. Moreover, they offer a streamlined process for insurance claims and reimbursements, making it easier for patients to offset the costs of their diabetes care devices. Along with this, hospital pharmacies offer a comprehensive range of diabetes care devices, giving patients various options to choose from.

Analysis by End User:

  • Hospitals
  • Homecare
  • Diagnostic Centers
  • Ambulatory Surgery Centers

Hospitals leads the market with around 40.5% of market share in 2025, as they offer a one-stop solution for all medical needs, making it easier for patients to get all their diabetes-related services, including consultations, treatments, and devices. Furthermore, they employ specialists in endocrinology and diabetes care, ensuring that patients receive expert advice and treatment. In addition, hospitals have the resources to handle diabetes-related emergencies, such as diabetic ketoacidosis, which standalone clinics may not be equipped for.

Apart from this, hospital-based care is often covered by insurance plans, making it a more accessible option for many patients. Moreover, the sheer number of patients that hospitals serve ensures that they purchase diabetes care devices in bulk, thus contributing to their large share of the market. Along with this, they are subjected to strict quality control standards, which provide assurance of the efficacy and safety of the diabetes care devices used.

Regional Analysis:

  • North America
  • United States
  • Canada
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

In 2025, North America accounted for the largest market share of over 38.6%. The region has one of the highest rates of diabetes in the world, which leads to increased demand for diabetes care devices. Furthermore, the region boasts a well-developed healthcare system with widespread availability of advanced medical technologies, including diabetes care devices. Additionally, the presence of comprehensive insurance plans, which cover diabetes treatment and devices, making it convenient for patients to access the care they need, is positively influencing the market growth.

Besides this, North America hosts some of the leading companies in medical device manufacturing that are continuously updating and advancing diabetes care technology. In addition, the escalating awareness about diabetes and its management among regional consumers is acting as another growth-inducing factor. Moreover, the imposition of supportive policies and initiatives by regional governments to combat diabetes and provide access to high-quality treatment is favoring the market growth.

Key Regional Takeaways:

United States Diabetes Care Devices Market Analysis

The U.S. diabetes care devices market is increasing steadily due to the prevalence of diabetes and high healthcare expenditures. According to the CDC, around 37.3 million people in America suffer from diabetes, and this makes 11.3% of the total population in the United States. This raised number is raising the demand for diabetes management products. In 2023, an estimated amount of USD 327 billion were spent on U.S. healthcare on diabetes care, most of which goes into medical devices, including CGMs and insulin pumps.

Leading players in this market are Medtronic, Abbott, and Dexcom, which are moving the technologies along to include the integrated insulin delivery systems. The continued efforts towards accessibility and affordability of diabetes devices will further drive the market growth. As the country continues to push for integration of digital health, telemedicine for diabetes care is expected to augment device adoption, ensuring continued momentum in the market.

Europe Diabetes Care Devices Market Analysis

The market for diabetes care devices is increasing in Europe with increasing prevalence of diabetes and increased investment in health. IDF states that 2023 was the year when more than 60 million people were living with diabetes in Europe. Germany and UK are well ahead in using advanced diabetes care devices. These include insulin pens, CGMs, and insulin pumps. Further, cost-effective health care seems to be creating growth opportunities for the European as well as EU-wide markets.

There is a wide effort to curb chronic diseases that is also working for the industry's growth. Smart insulin pens, wireless glucose monitoring systems are other innovative products coming from leaders such as Roche and Bayer. The regulation framework in Europe about diabetes care products, safety and effectiveness in treatment, facilitates the innovation in market growth.

Asia Pacific Diabetes Care Devices Market Analysis

Asia Pacific diabetes care devices market is highly growing due to the increasing diabetes rates and geriatric population. IDF reports that more than 170 million people are suffering from diabetes, and the population of China and India is leading in this segment. An industrial report suggests that China's diabetes care market was at USD 4.7 billion in 2023, and considerable investments have been made into the advanced medical devices, which include CGMs and insulin delivery systems. In India, the diabetes care device markets also grow as more emphasis is being put upon cost-effective and affordable solutions.

Healthcare infrastructure growth and adoption of digital health solutions have spurred the demand for diabetes devices in this region. Innovation and access to products is also driven through partnerships between international and local players, such as Abbott and Medtronic collaborating in India. Government-backed programs for increasing the accessibility of better diabetes care in the region continue to fuel the growth of this market.

Latin America Diabetes Care Devices Market Analysis

In terms of the high prevalence of diabetes in Latin America, Brazil accounts for over 15.7 million adults who are already affected, a figure provided by the International Diabetes Federation (IDF) of 2021. This explains why the high prevalence of the disease has driven up healthcare costs in the country. As per industrial reports, in 2021, a total of 42.93 billion USD had been allocated toward diabetes care within Brazil. Given the trend this amount is believed to increase profoundly in the forthcoming years, surging to a total of about 48.31 billion in 2030 and 51.44 billion in 2045. In other words, it is directly proportional to increasing disease burden.

Moreover, the Brazilian government tries to expand the use of advanced technologies in the treatment of very high medical specialties like insulin pumps, continuous glucose monitors (CGMs), and insulin pens, along with expanding the public knowledge and patient's perception. The overall approach to that is driven by Novo Nordisk, Sanofi, and other key market players with very critical treatment options and increasingly adequate technologies for satisfying the present demand.

Middle East and Africa Diabetes Care Devices Market Analysis

The International Diabetes Federation (IDF) estimates around 73 million adults in the Middle East and North Africa, also known as the MENA region. The statistics show that the prevalence among adults in Saudi Arabia is nearly 17.7%, and about 4.27 million people are diagnosed with diabetes in the country, while South Africa is also the region's 'hot spot'. This boosting trend is due to the growing diabetes care market in the country. Current government action, such as healthcare initiatives that offer cheap access to diabetes care equipment, has been proved to impact the aspect comprehensively.

Saudi Arabia has also accentuated the healthcare infrastructure, and campaigns to educate the people about diabetes management. Therefore, the diabetes care market in Saudi Arabia is growing, as demand for insulin pumps and continuous glucose monitoring (CGM) devices is increasing along with other advanced solutions for efficient management of the disease.

Competitive Landscape:

Leadership companies are moving towards bringing next-generation products in the pipeline to market, such as smart insulin pens, CGM integrated devices and much accurate meters for checking the blood sugar. Additionally, major companies are developing partnership arrangements with health-care organisations, IT organizations and sometimes, competitors for designing new devices jointly. Moreover, key companies have developed differentiated product lines which suit emerging geographies where the risk of developing the disease is escalating.

They are also integrating digital technologies, such as data analytics and telehealth, into their devices to allow real-time monitoring and data collection, which can be crucial for effective diabetes management. Several companies are investing in education programs and materials to help users understand how to manage diabetes effectively. Along with this, they are leveraging online platforms for direct sales and customer engagement.

The report provides a comprehensive analysis of the competitive landscape in the diabetes care devices market with detailed profiles of all major companies, including:

  • Abbott Laboratories
  • ACON Laboratories Inc.
  • Ascensia Diabetes Care Holdings AG (PHC Holdings Corporation)
  • Becton Dickinson and Company
  • Bionime Corporation
  • Dexcom Inc.
  • F. Hoffmann-La Roche AG
  • Johnson & Johnson
  • Medtronic plc
  • Novo Nordisk A/S
  • Sinocare Inc.
  • Terumo Corporatio.

Key Questions Answered in This Report

  • How big is the diabetes care devices market?
  • What is the future outlook of diabetes care devices market?
  • What are the key factors driving the diabetes care devices market?
  • Which region accounts for the largest diabetes care devices market share?
  • Which are the leading companies in the global diabetes care devices market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Diabetes Care Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Blood Glucose Monitoring (BGM) Devices
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Self-Monitoring Devices
      • 6.1.2.2 Continuous Glucose Monitoring Devices
    • 6.1.3 Market Forecast
  • 6.2 Insulin Delivery Devices
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Pumps
      • 6.2.2.2 Pens
      • 6.2.2.3 Syringes
      • 6.2.2.4 Jet Injectors
    • 6.2.3 Market Forecast

7 Market Breakup by Distribution Channel

  • 7.1 Hospital Pharmacies
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Retail Pharmacies
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Diabetes Clinics/Centers
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Online Pharmacies
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Homecare
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Diagnostic Centers
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Ambulatory Surgery Centers
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 ACON Laboratories Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Ascensia Diabetes Care Holdings AG (PHC Holdings Corporation)
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Becton Dickinson and Company
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Bionime Corporation
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
    • 14.3.6 Dexcom Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 F. Hoffmann-La Roche AG
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8 Johnson & Johnson
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Medtronic plc
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Novo Nordisk A/S
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Sinocare Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
    • 14.3.12 Terumo Corporation
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Diabetes Care Devices Market: Major Drivers and Challenges
  • Figure 2: Global: Diabetes Care Devices Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Diabetes Care Devices Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Diabetes Care Devices Market: Breakup by Type (in %), 2025
  • Figure 5: Global: Diabetes Care Devices Market: Breakup by Distribution Channel (in %), 2025
  • Figure 6: Global: Diabetes Care Devices Market: Breakup by End User (in %), 2025
  • Figure 7: Global: Diabetes Care Devices Market: Breakup by Region (in %), 2025
  • Figure 8: Global: Diabetes Care Devices (Blood Glucose Monitoring (BGM) Devices) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 9: Global: Diabetes Care Devices (Blood Glucose Monitoring (BGM) Devices) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 10: Global: Diabetes Care Devices (Insulin Delivery Devices) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Diabetes Care Devices (Insulin Delivery Devices) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Diabetes Care Devices (Hospital Pharmacies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Diabetes Care Devices (Hospital Pharmacies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Diabetes Care Devices (Retail Pharmacies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Diabetes Care Devices (Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Diabetes Care Devices (Diabetes Clinics/Centers) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Diabetes Care Devices (Diabetes Clinics/Centers) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Diabetes Care Devices (Online Pharmacies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Diabetes Care Devices (Online Pharmacies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Diabetes Care Devices (Other Distribution Channels) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Diabetes Care Devices (Other Distribution Channels) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Diabetes Care Devices (Hospitals) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Diabetes Care Devices (Hospitals) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: Global: Diabetes Care Devices (Homecare) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: Global: Diabetes Care Devices (Homecare) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: Global: Diabetes Care Devices (Diagnostic Centers) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: Global: Diabetes Care Devices (Diagnostic Centers) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: Global: Diabetes Care Devices (Ambulatory Surgery Centers) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: Global: Diabetes Care Devices (Ambulatory Surgery Centers) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: North America: Diabetes Care Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: North America: Diabetes Care Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: United States: Diabetes Care Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: United States: Diabetes Care Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: Canada: Diabetes Care Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: Canada: Diabetes Care Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: Asia-Pacific: Diabetes Care Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: Asia-Pacific: Diabetes Care Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: China: Diabetes Care Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: China: Diabetes Care Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: Japan: Diabetes Care Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: Japan: Diabetes Care Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: India: Diabetes Care Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: India: Diabetes Care Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: South Korea: Diabetes Care Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: South Korea: Diabetes Care Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: Australia: Diabetes Care Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: Australia: Diabetes Care Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: Indonesia: Diabetes Care Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: Indonesia: Diabetes Care Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: Others: Diabetes Care Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: Others: Diabetes Care Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: Europe: Diabetes Care Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: Europe: Diabetes Care Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: Germany: Diabetes Care Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: Germany: Diabetes Care Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: France: Diabetes Care Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: France: Diabetes Care Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: United Kingdom: Diabetes Care Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: United Kingdom: Diabetes Care Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: Italy: Diabetes Care Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: Italy: Diabetes Care Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: Spain: Diabetes Care Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: Spain: Diabetes Care Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: Russia: Diabetes Care Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: Russia: Diabetes Care Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: Others: Diabetes Care Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: Others: Diabetes Care Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: Latin America: Diabetes Care Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: Latin America: Diabetes Care Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: Brazil: Diabetes Care Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 71: Brazil: Diabetes Care Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 72: Mexico: Diabetes Care Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 73: Mexico: Diabetes Care Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 74: Others: Diabetes Care Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 75: Others: Diabetes Care Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 76: Middle East and Africa: Diabetes Care Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 77: Middle East and Africa: Diabetes Care Devices Market: Breakup by Country (in %), 2025
  • Figure 78: Middle East and Africa: Diabetes Care Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 79: Global: Diabetes Care Devices Industry: SWOT Analysis
  • Figure 80: Global: Diabetes Care Devices Industry: Value Chain Analysis
  • Figure 81: Global: Diabetes Care Devices Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Diabetes Care Devices Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Diabetes Care Devices Market Forecast: Breakup by Type (in Million USD), 2026-2034
  • Table 3: Global: Diabetes Care Devices Market Forecast: Breakup by Distribution Channel (in Million USD), 2026-2034
  • Table 4: Global: Diabetes Care Devices Market Forecast: Breakup by End User (in Million USD), 2026-2034
  • Table 5: Global: Diabetes Care Devices Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: Diabetes Care Devices Market: Competitive Structure
  • Table 7: Global: Diabetes Care Devices Market: Key Players